Polymorphisms of genes encoding tumor necrosis factor-alpha, interleukin-10, cluster of differentiation-14 and interleukin-1ra in critically ill patients

Journal of Critical Care

Volumn 25, Issue 3, 2010, Pages 542.e1-542.e8

  Surbatovic, Maja ^a   Grujic, Krasimirka ^b   Cikota, Bojana ^a   Jevtic, Miodrag ^a   Filipovic, Nikola ^a   Romic, Predrag ^a   Strelic, Natasa ^a   Magic, Zvonko ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Clinical Hospital Center   (Serbia)

Author keywords

Gene polymorphisms; Sepsis; Trauma

Indexed keywords

CD14 ANTIGEN; CLUSTER OF DIFFERENTIATION 14; GENE PRODUCT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MICROORGANISM DETECTION; MORTALITY; OUTCOME ASSESSMENT; PERITONITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; RISK FACTOR; SEPSIS; SURVIVAL RATE;

EID: 84055218634     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.12.003     Document Type: Article

References (36)

1. Jean-Baptiste E. Cellular mechanism in sepsis. J Intensive Care Med 2007, 22:63-72.
2. Sorensen T.I., Nielsen G.G., Andersen P.K., et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318:727-732.
3. Read R.C., Teare D.M., Pridmore A.C., et al. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009, 37:1237-1243.
4. De Maio A., Torres M.B., Reeves R.H. Genetic determinants influencing the response to injury, inflammation and sepsis. Shock 2005, 23:11-17.
5. Ledoux D., Canivet J.L., Preiser J.C., et al. SAPS 3 admission score: an external validation in general intensive care population. Intensive Care Med 2008, 34:1873-1877.
6. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
7. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
8. Moreno R.P., Vincent J.L., Matos R., et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective multicentre study. Intensive Care Med 1999, 25:686-696.
9. Tang G.J., Huang S.L., Yien H.W., et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736.
10. Gibot S., Cariou A., Drouet L., et al. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002, 30:969-973.
11. Witkin S.S., Gerber S., Ledger J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. CID 2002, 34:204-209.
12. Gordon A.C., Lagan A.L., Aganna E., et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicenter study. Genes Immun 2004, 5:631-640.
13. Mira J.P., Cariou A., Grall F., et al. Association of TNF2, TNF-α promoter polymorphism, with septic shock susceptibility and mortality. A multicenter study. JAMA 1999, 282:561-568.
14. O'Keefe G.E., Hybki D.L., Munford R.S. The G → A single nucleotide polymorphism at the -308 position in the tumor necrosis factor alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002, 52:817-825.
15. Watanabe E., Hirasawa H., Oda S., et al. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med 2005, 33:89-97.
16. Barber R.C., Aragaki C.C., Rivera-Chavez F.A., et al. TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004, 41:808-813.
17. Reid C.L., Perrey C., Pravica V., et al. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 2002, 30:2216-2221.
18. Dianliang Z., Lieshou L., Zhiwei J., et al. Association of plasma levels of tumor necrosis factor (TNF)-α and its soluble receptors, two polymorphisms of the TNF gene with acute severe pancreatitis and early septic shock due to it. Pancreas 2003, 26:339-343.
19. Powell J.J., Fearon K.C., Siriwardena A.K., et al. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1-receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001, 129:633-640.
20. Waterer G.W., Wunderink R.G. Science review: genetic variability in the systemic inflammatory response. Crit Care 2003, 7:308-314.
21. Papachristou G.I., Clermont G., Sharma A., et al. Risk and markers of severe acute pancreatitis. Gastroenterol Clin North Am 2007, 36:277-296.
22. Zhang D.L., Zheng H.M., Yu B.J., et al. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol 2005, 11:4409-4413.
23. Sabelnikovs O., Nikitina-Zake L., Zhuravlova J., et al. Association of IL-10 promoter polymorphism -1082 G/A with adverse outcome in severe sepsis and septic shock. Crit Care 2009, 13(Suppl. 1):P355. (abstr).
24. Stanilova S.A., Miteva L.D., Karakolev Z.T., et al. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006, 32:260-266.
25. Schaaf B.M., Boehmke F., Esnaashari H., et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003, 168:476-480.
26. Shu Q., Fang X., Chen Q., et al. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J 2003, 116:1756-1759.
27. Gong M.N., Thompson B.T., Williams P.L., et al. Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J 2006, 27:674-681.
28. Sutherland A.M., Walley K.R., Russell J.A. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor 2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005, 33:638-644.
29. Yuan F.F., Marks K., Wong M., et al. Clinical relevance of TLR2, TLR4, CD14 and FcγRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2008, 86:268-270.
30. Agnese D.M., Calvano J.E., Hahm S.J., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002, 186:1522-1525.
31. Hubacek J.A., Stuber F., Frohlich D., et al. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun 2000, 1:405-407.
32. Nakada T., Hirasawa H., Oda S., et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor and interleukin-10 gene polymorphisms on clinical outcome in Japanese critically Ill patients. J Surg Res 2005, 129:322-328.
33. Gu W., Dong H., Jiang D.P., et al. Functional significance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population. Crit Care Med 2008, 36:2274-2280.
34. Fang X.M., Schroder S., Hoeft A., et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999, 27:1330-1334.
35. Arnalich F., Lopez-Maderuelo D., Codoceo R., et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002, 127:331-336.
36. Ma P., Chen D., Pan J., et al. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002, 30:1046-1050.